FeesSafety
Pluang+

JELD-WEN launches offer to exchange 2027 notes for new secured notes due 2031 with added purchase option.

Company Fundamentals
29 Oct 2026, 04:51 WIB
PRNewsWire
View Source
Neutral
JELD-WEN launches offer to exchange 2027 notes for new secured notes due 2031 with added purchase option.

JELD-WEN Holding, Inc. has initiated an exchange offer allowing holders of its 4.875% Senior Notes due 2027 to swap these for new first lien senior secured notes due 2031. Eligible holders can also participate in a new money offer to purchase additional new notes up to $410.2 million. The offer includes incentives for early tendering and consent to amend the old notes' terms, aiming to improve financial flexibility by eliminating restrictive covenants and modifying default provisions. The exchange and consent solicitation will close by November 27, 2026, with key commitments already secured from major noteholders and lenders.

JELD-WEN's exchange offer and consent solicitation provide context for financial markets. For readers following Financials-sector US stocks, here is Pluang's market snapshot as of Oct 29, 2026 07:02 WIB: of 142 priced stocks, 90 rose and 50 fell. Notable movers include RIOT at USD 14.21 with a 1-day change of +4.79% and a typical hold time on Pluang of 18 days, HOOD at USD 90.09 down 4.73% with a 76-day hold time, and AON at USD 316.59 up 4.66% with a 124-day hold time. Pluang order activity shows RIOT with 40% sell and 60% buy, HOOD with 41% sell and 59% buy, and AON with 68% sell and 32% buy.

More News

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

Market News
Neutral
2 hours ago
FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...

Market News
Bullish
2 hours ago
LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 1...

Market News
Bullish
2 hours ago
Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Kirby McInerney LLP is investigating NVE Corporation for possible violations of federal securities laws after the company reported a 47% revenue decline and a 33.7% stock price drop following its Q2 fiscal 2027 results. The revenue fall was attribute...

Market News
Bearish
4 hours ago
Pump.fun launches app for trading perpetual futures on 300+ markets with up to 50x leverage.

Pump.fun launches app for trading perpetual futures on 300+ markets with up to 50x leverage.

Pump.fun's new app enables trading of perpetual futures across more than 300 Hyperliquid markets, including cryptocurrencies, stocks, and commodities. Users can fund positions with USDC or Solana, take long or short exposure, and use leverage up to 5...

Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App